HIV Diagnoses and Care among Transgender Persons and Comparison with Men Who Have Sex with Men: New York City, 2006-2011
OBJECTIVES:
We
measured HIV care outcomes of transgender persons, who have high HIV infection
rates but are rarely distinguished from men who have sex with men (MSM) in HIV
surveillance systems.
METHODS:
New York
City's surveillance registry includes HIV diagnoses since 2000 and HIV
laboratory test results for transgender persons since 2005. We determined
immunological status at diagnosis, delayed linkage to care, and nonachievement
of viral suppression 1 year after diagnosis for transgender persons diagnosed
with HIV in 2006 to 2011 and compared transgender women with MSM.
RESULTS:
In 2006
to 2011, 264 of 23 805 persons diagnosed with HIV were transgender (1%): 98%
transgender women and 2% transgender men. Compared with MSM, transgender women
had similar CD4 counts at diagnosis and rates of concurrent HIV/AIDS and
delayed linkage to care but increased odds of not achieving suppression
(adjusted odds ratio = 1.56; 95% confidence interval = 1.13, 2.16).
CONCLUSIONS:
Compared
with MSM, transgender women in New York City had similar immunological status
at diagnosis but lagged in achieving viral suppression. To provide appropriate
assistance along the HIV care continuum, HIV care providers should accurately
identify transgender persons.
- 1At the time of this analysis, all of the authors were with the HIV Epidemiology and Field Services Program, New York City Department of Health and Mental Hygiene, New York, NY.
No comments:
Post a Comment